P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.
Vaccines Medical Affairs, Pfizer UK Ltd, Tadworth, United Kingdom.
Vector Borne Zoonotic Dis. 2023 Apr;23(4):142-155. doi: 10.1089/vbz.2022.0067.
Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe and the incidence of LB is increasing owing to an expansion in tick habitats. However, LB surveillance is quite heterogeneous across the continent, and for those countries with publicly available data, it is difficult to understand the differences in incidence between countries. The objective of our study was to summarize the publicly available data from surveillance for LB in the form of surveillance reports and/or dashboards and to compare the information available for various countries. We identified publicly available LB data (online dashboards and surveillance reports) in the European Union, European Economic Area, the United Kingdom, Russia, and Switzerland. Of the 36 countries studied, 28 had LB surveillance in place; 23 had surveillance reports, and 10 had dashboards. The dashboards, in general, had more granular data compared with the surveillance reports, but the reports covered longer time periods. LB annual cases, incidence, age, and sex-stratified LB data; manifestations; and regional data were available for most of the countries. LB case definitions varied significantly among the countries. The study highlights large differences in LB surveillance systems, including representativeness, case definitions, type of data available that might inhibit comparison of data between countries and accurate determination of burden of disease, and risk groups within countries. Standardization of case definitions across countries would be a useful first step enabling comparisons between countries and contribute to recognizing the true burden of LB in Europe.
莱姆病(LB)是欧洲最常见的蜱传疾病,由于蜱栖息地的扩大,LB 的发病率正在上升。然而,欧洲大陆的 LB 监测情况差异很大,对于那些有公开可用数据的国家,很难理解各国之间发病率的差异。我们的研究目的是总结 LB 监测的公开可用数据,形式为监测报告和/或仪表板,并比较各国的可用信息。我们在欧盟、欧洲经济区、英国、俄罗斯和瑞士确定了 LB 监测的公开可用数据(在线仪表板和监测报告)。在所研究的 36 个国家中,有 28 个国家开展了 LB 监测;23 个国家有监测报告,10 个国家有仪表板。一般来说,仪表板的数据比监测报告更详细,但报告涵盖的时间周期更长。大多数国家都有 LB 年度病例、发病率、年龄和性别分层的 LB 数据;表现;以及区域数据。LB 病例定义在各国之间存在显著差异。该研究突出了 LB 监测系统的巨大差异,包括代表性、病例定义、可用数据类型,这些可能会阻碍国家之间的数据比较和准确确定疾病负担,以及国家内部的风险群体。在国家之间标准化病例定义将是一个有用的第一步,使国家之间能够进行比较,并有助于认识到欧洲 LB 的真实负担。